Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CJ.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HZ.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.31NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.28NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GB.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FY.2.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.13NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.11NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.4.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FD.2.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FP.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FD.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FG.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.78NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-18318.6China
EG.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.45NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.16.20NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.34.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JD.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.25NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.79NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HP.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FU.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.84NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EU.1.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.97NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CH.1.1.14NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-18660.1China
FE.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.17NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.3.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.95NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
ET.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.34NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.31NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.22NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EN.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.2.3.14NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.13NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DV.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.11.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GJ.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HJ.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.101NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.1.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.2.3.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EY.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.35NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used